Imagine the injection site as a tiny wound
Key highlights Tirzepatide (also known by FDA-approved brand names Mounjaro and Zepbound) is a dual receptor agonist (GLP-1/GIP) that helps reduce appetite, control blood sugar, and promote greater weight loss than single receptor GLP-1 receptor agonists, such as semaglutide
Weekly dosing is great for those with severe deficiencies or major neurological symptoms
BPC-157 has been studied for its potential role in supporting: Tendon and ligament healing Muscle recovery Joint tissue health Gut lining health Blood flow to injured tissue This has made it popular in conversations around sports injuries, chronic tendon pain, and recovery from overuse
[DOI] [Google Scholar] 165.Boban Blagaic A., Turcic P., Blagaic V., Dubovecak M., Jelovac N., Zemba M., Radic B., Becejac T., Stancic Rokotov D., Sikiric P